Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin AmyloidPablo García‐Pavía, Thibaud Damy, Peter van der Meer et al.|New England Journal of Medicine|2023Cited by 233
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze‐Fan Chao, Robert P. Giugliano, Shih‐Ann Chen et al.|European Heart Journal|2018Cited by 106